Program overview
Context
Indication: Carcinoma, Renal Cell
Mechanism: Unknown
Modality: Unknown
Sponsor: Novartis Pharmaceuticals
Operational Burden Signal
Pazopanib
Pazopanib is flagged as operational burden signal because public records show public results not found after completion, operational burden. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Scores
Risk-signal summary
Registry: 0/5
Timeline: 1/5
Recruitment burden: 3/5
Results availability: 3/5
Program risk: 4/5
Evidence
Public links
https://clinicaltrials.gov/study/NCT01147822 | https://clinicaltrials.gov/study/NCT02383251 | https://clinicaltrials.gov/study/NCT01280201
Linked trials
Trial-level signal details
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT01147822 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | large_enrollment_target_signal | rare_population_signal | strict_eligibility_signal |
| NCT02383251 | Low Signal (COMPLETED) | stale_update_signal | Completed No Results Found Signal | rare_population_signal |
| NCT01280201 | Low Signal (COMPLETED) | stale_update_signal | Low Signal | rare_population_signal |